Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Exelixis, Inc.(EXEL) | 965,866 | 878,533 | -87,333 | $32.2K | $32.4K | 17.93% | +$272 |
| United Therapeutics Corporation(UTHR) | 92,057 | 98,228 | +6,171 | $32.5K | $30.3K | 16.74% | -$2.2K |
| Cardinal Health, Inc.(CAH) | 208,845 | 188,745 | -20,100 | $24.7K | $26.0K | 14.38% | +$1.3K |
| Supernus Pharmaceuticals Inc | 0 | 431,986 | +431,986 | $0 | $14.1K | 7.82% | +$14.1K |
| Jazz Pharmaceuticals plc(JAZZ) | 105,803 | 100,703 | -5,100 | $13.0K | $12.5K | 6.91% | -$528 |
| Enanta Pharmaceuticals, Inc.(ENTA) | 2,117,390 | 2,116,586 | -804 | $12.2K | $11.7K | 6.46% | -$491 |
| GSK plc(GSK) | 0 | 272,000 | +272,000 | $0 | $10.5K | 5.83% | +$10.5K |
| Indivior Plc | 935,680 | 965,368 | +29,688 | $11.6K | $9.2K | 5.09% | -$2.4K |
| Sanofi(SNY) | 149,196 | 149,096 | -100 | $7.2K | $8.3K | 4.57% | +$1.1K |
| BioNTech SE(BNTX) | 88,663 | 87,563 | -1,100 | $10.1K | $8.0K | 4.41% | -$2.1K |
| Avadel Pharmaceuticals | 0 | 950,000 | +950,000 | $0 | $7.4K | 4.11% | +$7.4K |
| Alkermes plc(ALKS) | 238,136 | 207,822 | -30,314 | $6.8K | $6.9K | 3.79% | +$13 |
| Vanda Pharmaceuticals Inc.(VNDA) | 378,762 | 754,381 | +375,619 | $1.8K | $3.5K | 1.91% | +$1.6K |
| Mural Oncology Plc | 70,163 | 70,263 | +100 | $226 | $89 | 0.05% | -$137 |
| Biogen Inc.(BIIB) | 108,923 | 0 | -108,923 | $16.7K | $0 | — | -$16.7K |